US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

2,053.18

-43.3257-2.07%

Number of Gainers:4

Number of Losers:5

Number of Flat:2

PE:- -

High:2,106.70

Open:2,105.72

Low:2,045.68

Close:2,096.51

Volume:60.72M

Turnover:988.71M

Market Cap:227.21B

Float Cap:226.50B

Loading ...

Quest Diagnostics CEO Jim Davis to Speak at Baird Global Healthcare Conference

August 2026's Highlighted Stocks That May Be Trading Below Estimated Value

Simply Wall St.

Quest Diagnostics CFO Sam Samad to Speak at Morgan Stanley Global Healthcare Conference

Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio

MT Newswires Live

Tonix Pharma Director Richard H. Bagger Acquires Common Shares Worth $12,600

Wall Street Analysts Are Bullish on Top Healthcare Picks

Quest Diagnostics - to Launch New Ad-Detect Multi-Biomarker Lab Test Nationwide at Month-End

THOMSON REUTERS

Quest Diagnostics - to Incorporate Roche Ptau217 Test in Ad-Detect Panels in 2027

THOMSON REUTERS

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS

Funds: What a Top Biotech Fund is Buying Now

Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Quest Diagnostics Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Moderna Inc. Stock Advances 8.9%, Outperforms Peers

Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Viatris' China Policy Concerns Overstated, UBS Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK4583/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":2053.183,"timestamp":1787947199999,"preClose":2096.5088,"halted":0,"volume":60716755,"delay":0,"changeRate":-0.020666,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-43.325684,"latestTime":"08-28 16:00:00 EDT","open":2105.7156,"high":2106.701,"low":2045.6775,"amount":988710159.37901,"amplitude":0.029107,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.7497,"peRate":-76.582617,"turnoverRate":0.022487,"increases":4,"decrements":5,"flats":1,"marketCap":227208543698.5,"floatMarketCap":226503564502.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","high":2106.701,"amplitude":0.029107,"preClose":2096.5088,"low":2045.6775,"pbRate":"6.7497","latestPrice":2053.183,"volume":60716755,"delay":0,"open":2105.7156,"prevYearClose":1682.3505,"prevWeekClose":2059.042,"prevMonthClose":1882.546,"prevQuarterClose":1802.0435,"fiveDayClose":2059.042,"twentyDayClose":1882.546,"sixtyDayClose":1811.7245,"secType":"PLATE","market":"US","turnoverRate":0.022487,"peRate":-76.582617,"marketCap":227208543698.5,"floatMarketCap":226503564502.5,"timestamp":1787947199999,"nameCN":"Monkeypox Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4583\",,,,undefined,":{"bkCode":"BK4583","up":4,"down":5,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4583\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662730367","title":"Quest Diagnostics CEO Jim Davis to Speak at Baird Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662730367","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662730367?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:30","pubTimestamp":1787664625,"startTime":"0","endTime":"0","summary":"Quest Diagnostics CEO Jim Davis to speak at Baird Global Healthcare ConferenceQuest Diagnostics CEO Jim Davis will speak at the Baird 2026 Global Healthcare Conference in New York City on Sept. 15, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDLc757M2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2506951958.HKD","BK4583","BK4196","LU0823417737.USD","LU0823417653.USD","LU2506952170.USD","LU0950375773.USD","LU1854103824.USD","LU2506951875.HKD","DGX","LU1854104046.USD","BK4567","LU2506952097.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662082842","title":"August 2026's Highlighted Stocks That May Be Trading Below Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2662082842","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662082842?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:08","pubTimestamp":1787591280,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has dropped by 1.2%, although it has seen a significant rise of 18% over the past year, with earnings forecasted to grow by 17% annually. In this context, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to capitalize on longer-term growth prospects.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/7013000-choice2-main-header/1585186648241","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7013000-choice2-main-header/1585186648241"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/banks/nasdaq-inbk/first-internet-bancorp/news/august-2026s-highlighted-stocks-that-may-be-trading-below-es","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/banks/nasdaq-inbk/first-internet-bancorp/news/august-2026s-highlighted-stocks-that-may-be-trading-below-es","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4135","EBS","INBK","BK4139","WLTH","BK4583","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661037279","title":"Quest Diagnostics CFO Sam Samad to Speak at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2661037279","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661037279?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:03","pubTimestamp":1787576594,"startTime":"0","endTime":"0","summary":"Quest Diagnostics CFO Sam Samad to speak at Morgan Stanley Global Healthcare ConferenceQuest Diagnostics will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Sept. 14, 2026, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL2qs38t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854104046.USD","LU0950375773.USD","DGX","LU1363072403.SGD","BK4585","LU2271345857.HKD","BK4516","LU2506952170.USD","BK4583","LU1074936037.SGD","LU0390134368.USD","LU2506951875.HKD","LU2089283258.USD","BK4504","LU2028103732.USD","LU0882574139.USD","LU1988902786.USD","BK4588","LU1668664300.SGD","LU1989772840.SGD","LU0210528500.USD","LU0053666078.USD","LU1732799900.SGD","LU0234570918.USD","LU0557290698.USD","LU1791710582.SGD","IE00B775SV38.USD","LU0225283273.USD","LU1854103824.USD","LU0971096721.USD","IE00BKVL7J92.USD","LU0098860793.USD","LU0314104364.USD","LU0267386448.USD","BK4127","LU1244550577.SGD","IAI","KBWB","LU1989772923.USD","IE00BZ1G4Q59.USD","BK4534","LU0158827948.USD","LU2111349929.HKD","LU2133065610.SGD","LU0320765646.SGD","LU1162221912.USD","LU2089284900.SGD","LU2506951958.HKD","LU0106261372.USD","LU1064131342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276223","title":"Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276223","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276223?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:24","pubTimestamp":1787574276,"startTime":"0","endTime":"0","summary":"Quest Diagnostics  said Monday it is adding Roche's Elecsys Phospho-Tau Plasma blood test to its AD-Detect portfolio of biomarker tests to detect Alzheimer's disease.The company said it plans to offer a laboratory test service based on Elecsys in Q4 and incorporate the Roche test into future AD-Detect panels in 2027.Quest said the US Food and Drug Administration has cleared Roche's Elecsys blood test to assess amyloid pathology associated with Alzheimer's disease across primary and specialty care settings.Quest also said it will launch its newest AD-Detect lab-developed blood test with low 10% indeterminate rate so more patients can receive an actionable insight.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0823417737.USD","LU0823417653.USD","LU2506951875.HKD","DGX","BK4567","LU0950375773.USD","LU2506951958.HKD","BK4585","BK4588","LU1854103824.USD","LU2506952097.USD","LU1854104046.USD","BK4583","LU2506952170.USD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661360276","title":"Tonix Pharma Director Richard H. Bagger Acquires Common Shares Worth $12,600","url":"https://stock-news.laohu8.com/highlight/detail?id=2661360276","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661360276?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:01","pubTimestamp":1787572868,"startTime":"0","endTime":"0","summary":"Tonix Pharma director Richard H. Bagger acquires common shares worth $12,600Tonix Pharmaceuticals director Richard H. Bagger bought 1,000 common shares in an open-market purchase at USD 12.6 each.His ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL4S9wVH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Tonix Pharma Director Richard H. Bagger Acquires Common Shares Worth $12,600","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","TNXP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275900","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275900","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275900?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:30","pubTimestamp":1787571030,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Tonix Pharma (TNXP), Pfizer (PFE) and Pacira Pharmac...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-309?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-309?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999002232.USD","IE00BBT3K403.USD","SG9999001176.SGD","BK4592","IE00B19Z3B42.SGD","LU0306806265.USD","IE000M9KFDE8.USD","LU0225284248.USD","LU0225771236.USD","LU0289739699.SGD","IE00B3T34201.USD","BK4585","BK4007","BK4583","BK4581","LU0868494617.USD","LU1023059063.AUD","LU0321505439.SGD","LU0170899867.USD","LU0122379950.USD","LU1883839398.USD","BK4139","BK4588","LU0058720904.USD","LU0234572021.USD","IE0002270589.USD","LU1894683264.USD","BK4533","SG9999001176.USD","SG9999003800.SGD","LU1066051498.USD","PFE","SG9999002224.SGD","LU2596442595.SGD","LU0321505868.SGD","IE00B19Z3581.USD","BK4550","LU0306807586.USD","BK4599","IE00BLSP4452.SGD","LU1066053197.SGD","LU1894683348.USD","BK4568","SGXZ57979304.SGD","LU0456855351.SGD","IE00BLSP4239.USD","BK4534","LU0985481810.HKD","OZEM","SG9999013999.USD","LU1057294990.SGD","TNXP","SG9999011175.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275836","title":"Quest Diagnostics - to Launch New Ad-Detect Multi-Biomarker Lab Test Nationwide at Month-End","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275836","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275836?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:25","pubTimestamp":1787570754,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L08M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2506952170.USD","BK4585","LU0950375773.USD","LU2506951875.HKD","BK4567","LU1854103824.USD","DGX","LU2506952097.USD","BK4588","LU0823417653.USD","LU1854104046.USD","LU2506951958.HKD","LU0823417737.USD","BK4583","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273076","title":"Quest Diagnostics - to Incorporate Roche Ptau217 Test in Ad-Detect Panels in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273076?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:25","pubTimestamp":1787570754,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L08M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2506951958.HKD","LU0823417653.USD","LU0823417737.USD","LU0950375773.USD","LU2506952097.USD","LU1854104046.USD","BK4588","LU2506951875.HKD","DGX","BK4583","BK4196","LU2506952170.USD","BK4567","LU1854103824.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278374","title":"EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278374?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567503,"startTime":"0","endTime":"0","summary":"EU Commission approves Gilead Trodelvy-Keytruda combo for first-line PD-L1+ metastatic TNBCEuropean Commission granted marketing authorization for Trodelvy with Merck’s Keytruda in first-line metastat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL4gZS8y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU1585245621.USD","LU2357627491.SGD","LU0289739699.SGD","LU2468319806.SGD","BK4566","LU1037948897.HKD","LU1934455277.USD","LU0114720955.EUR","LU0320765992.SGD","LU0109394709.USD","LU1934455194.USD","IBB","BK4585","LU0859254822.USD","LU0965509283.SGD","TBXU","LU1037948541.HKD","LU0823416689.USD","LU1430594728.SGD","SG9999015978.USD","LU1061106388.HKD","LU1674673691.USD","GILD","LU0058720904.USD","SG9999015952.SGD","LU1066051498.USD","IE00B19Z3581.USD","LU1571399168.USD","SG9999015986.USD","BK4550","LU1934455863.HKD","LU0965509010.AUD","BBH","IE00B3T34201.USD","LU0861579265.USD","LU0882574055.USD","LU1023059063.AUD","LU2089984988.USD","BIB","IE00BZ1G4Q59.USD","MEDI","BK4583","LU1778281490.HKD","IBBQ","LU1057294990.SGD","TMED","LU0965508806.USD","IE0002270589.USD","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278323","title":"European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278323?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAMP4X3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","LU1057294990.SGD","IBB","BK4583","LU0114720955.EUR","SG9999015986.USD","TBXU","LU1674673428.USD","BMED","LU0320765992.SGD","LU0889565916.HKD","SG9999015945.SGD","SG9999015978.USD","LU0965509101.SGD","BIB","LU2089984988.USD","LU0882574055.USD","BK4532","LU1934455863.HKD","LU0861579265.USD","IE00B19Z3B42.SGD","BBH","BK4566","LU0234570918.USD","BK4585","LU0122379950.USD","LU1037948541.HKD","LU0058720904.USD","IBBQ","BK4568","LU1061106388.HKD","MEDI","LU2087621335.USD","BK4139","LU1037948897.HKD","IE00BKVL7J92.USD","LU2324357040.USD","IE00B7SZLL34.SGD","BK4588","LU0823416689.USD","LU0859254822.USD","GILD","LU1674673691.USD","LU1066053197.SGD","LU1585245621.USD","SG9999015952.SGD","LU0109394709.USD","IE00B19Z3581.USD","TMED","LU2357627491.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661213210","title":"Funds: What a Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661213210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661213210?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362200,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","REGN","LU1093756325.SGD","SG9999013999.USD","LU0859254822.USD","BIB","IBBQ","BK4568","LU0154245673.USD","SG9999001440.SGD","BBH","LU1430594728.SGD","IE00B894F039.SGD","LU0882574055.USD","LU2468319806.SGD","BK4583","LU0868494617.USD","LU1983299246.USD","IE00B4R5TH58.HKD","PBE","BK4585","SG9999001176.SGD","IE0002270589.USD","LU2324357040.USD","SG9999015952.SGD","SG9999015986.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU0058720904.USD","BMED","LU0965509101.SGD","MEDI","LU2357627491.SGD","BK4139","IE00B19Z9Z06.USD","LU0823434583.USD","BK4581","XBI","LU1674673691.USD","LU0053666078.USD","LU1934455863.HKD","LU2362541273.HKD","LU0061475181.USD","BK4588","IE00BFTCPJ56.SGD","IDNA","BK4567","LU2087621335.USD","LU2462157665.USD","LU1023059063.AUD","IE00BZ1G4Q59.USD","LU2362540622.SGD","SG9999015978.USD","GILD","LU1061106388.HKD","LU1057294990.SGD","SGXZ57979304.SGD","LU0823434740.USD","LU2242646821.SGD","PJP","BK4578","IBB","LU1069344957.HKD","LU1974910355.USD","IE00B19Z9P08.USD","LU1037948897.HKD","LU0154245756.USD","IE00B2B36J28.USD","LU0965509283.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4534","LU0289739699.SGD","LU1934455194.USD","LU1778281490.HKD","LU1066051498.USD","SG9999015945.SGD","IE0002141913.USD","LU1037948541.HKD","BK4550","LU0256863811.USD","SG9999001176.USD","BK4532","IE00BN0W2V16.EUR","LU0965509010.AUD","LU2417539215.USD","LU1066053197.SGD","LU2106854487.HKD","LU2023250504.SGD","LU0432979614.USD","TMED","BK4599","LU1585245621.USD","LU1917777945.USD","IE00BN0W2W23.USD","AMGN","LU2242652126.USD","IE00B19Z3581.USD","LU2362541513.USD","IE00B7SZLL34.SGD","LU2456880835.USD","IE00B3T34201.USD","LU1934455277.USD","IE00BJT1NW94.SGD","IE00BKVL7J92.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4533","BK4566","IE00BN0W2T93.GBP","LU0861579265.USD","LU0417517546.SGD","JAZZ","LU1093756168.USD","LU1035775433.USD","VRTX","BK4007","LU0079474960.USD","LU2112291526.USD","TBXU","LU0114720955.EUR","LU0965508806.USD","LU0109394709.USD","04332","IE00BZ9MQY76.HKD","LU1839511570.USD","LU2237438978.USD","LU1674673428.USD","LU0823416689.USD","LU0889565916.HKD","LU2236285917.USD","GNMX","LU0234570918.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661187372","title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","url":"https://stock-news.laohu8.com/highlight/detail?id=2661187372","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661187372?lang=en_us&edition=fundamental","pubTime":"2026-08-22 07:22","pubTimestamp":1787354576,"startTime":"0","endTime":"0","summary":"Gilead director Jeffrey Bluestone disposes of 5,000 common shares worth $727,333.60Gilead director Jeffrey Bluestone exercised stock options on Aug. 20, 2026, acquiring 5,000 shares at USD 61.35 to US","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL4cgVd7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357627491.SGD","SG9999015978.USD","LU2087621335.USD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU2468319806.SGD","LU1778281490.HKD","LU0965509101.SGD","LU0882574055.USD","LU0965508806.USD","BK4583","IBB","LU0859254822.USD","LU0965509010.AUD","LU1934455863.HKD","TBXU","LU1585245621.USD","IE00B3T34201.USD","LU1430594728.SGD","MEDI","LU0289739699.SGD","LU0234570918.USD","LU0320765992.SGD","SG9999015986.USD","LU1571399168.USD","LU1674673428.USD","SG9999015952.SGD","GILD","BK4588","BMED","BK4568","LU1023059063.AUD","LU0122379950.USD","LU0058720904.USD","LU0861579265.USD","LU2089984988.USD","BIB","IE00B7SZLL34.SGD","BK4139","IBBQ","IE00BSNM7G36.USD","LU0965509283.SGD","BK4532","LU1066053197.SGD","LU1674673691.USD","TMED","IE00B19Z3581.USD","SG9999015945.SGD","BK4566","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290475","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290475","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290475?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:24","pubTimestamp":1787347440,"startTime":"0","endTime":"0","summary":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  slipped 2.48% to $1.18 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.43% to 26,180.45 and the Dow Jones Industrial Average  rising 0.98% to 53,277.01.This was the stock's second consecutive day of losses.Inovio Pharmaceuticals Inc. closed 60.39% short of its 52-week high of $2.98, which the company achieved on September 9th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 1.07% to $270.24, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  rose 1.01% to $28.07.Trading volume  eclipsed its 50-day average volume of 3.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 21, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","INO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661905432","title":"Quest Diagnostics Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2661905432","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661905432?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:00","pubTimestamp":1787346000,"startTime":"0","endTime":"0","summary":"DJ Quest Diagnostics Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Quest Diagnostics Inc.  advanced 1.28% to $244.39 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.43% to 7,674.37 and the Dow Jones Industrial Average  rising 0.98% to 53,277.01.Quest Diagnostics Inc. closed 0.52% below its 52-week high of $245.68, which the company achieved on August 20th.The stock underperformed when compared to some of its competitors Friday, as UnitedHealth Group Inc.  rose 1.37% to $390.11, IQVIA Holdings Inc.  rose 1.47% to $259.82, and Centene Corp.  rose 1.37% to $65.02.Trading volume  eclipsed its 50-day average volume of 966,964.Data source: Dow Jones Market Data, FactSet. Data compiled August 21, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2506951958.HKD","LU0823417653.USD","LU0823417737.USD","LU0950375773.USD","LU2506952097.USD","LU1854104046.USD","BK4588","LU2506951875.HKD","DGX","BK4583","BK4196","LU2506952170.USD","BK4567","LU1854103824.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661972042","title":"Moderna Inc. Stock Advances 8.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661972042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661972042?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:33","pubTimestamp":1787344380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 8.9% to $145.13 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 26,180.45 and the Dow Jones Industrial Average rising 1.0% to 53,277.01.Moderna Inc. closed 17.8% below its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.24, Pfizer Inc. rose 1.0% to $28.07, and Gilead Sciences Inc. rose 1.87% to $146.12.Trading volume totaled 86.7 million, compared to the 50-day average of 13.0 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","LU0320765992.SGD","LU1839511570.USD","LU1430594728.SGD","LU1037948541.HKD","IDNA","LU0289739699.SGD","IBBQ","LGHT","LU1585245621.USD","LU0234570918.USD","LU1571399168.USD","BK4550","LU0122379950.USD","TBXU","LU1061106388.HKD","IE0002270589.USD","TMED","SG9999015978.USD","MEDI","BK4585","MRNX","BK4501","LU1057294990.SGD","BIB","LU0965509283.SGD","LU0861579265.USD","SG9999015952.SGD","LU2324357040.USD","WDNA","LU1934455863.HKD","BK4583","MRNA","BK4532","LU1674673691.USD","BBH","LU0965508806.USD","IBB","LU0058720904.USD","LU0823416689.USD","SG9999015986.USD","LU2357627491.SGD","LU1066053197.SGD","BK4551","LU1934455194.USD","GNOM","LU2112291526.USD","MRNY","BMED","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661940352","title":"Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2661940352","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661940352?lang=en_us&edition=fundamental","pubTime":"2026-08-22 01:58","pubTimestamp":1787335117,"startTime":"0","endTime":"0","summary":"Gilead declares Q3 2026 dividend of R$ 0.24 per unitGilead Sciences set a Q3 2026 distribution of R$ 0.24 per unit for BRGILDBDR 000.Last day to trade with rights: Sept. 11, 2026.Payment date: Oct. 5,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL12Yy9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","LU1037948897.HKD","LU2089984988.USD","TMED","BK4550","BK4583","LU2112291526.USD","LU1585245621.USD","LU2357627491.SGD","BK4585","LU1674673691.USD","LU1037948541.HKD","LU0122379950.USD","LU1023059063.AUD","BK4568","IE0002270589.USD","BBH","IE00B3T34201.USD","SG9999015986.USD","BK4578","SG9999015952.SGD","LU0859254822.USD","LU0965508806.USD","LU0965509101.SGD","IE00BSNM7G36.USD","LU0320765992.SGD","BIB","LU2468319806.SGD","LU0114720955.EUR","LU0965509283.SGD","BK4588","IE00B19Z3B42.SGD","LU0889565916.HKD","BK4139","LU2324357040.USD","IBB","MEDI","IE00B7SZLL34.SGD","BK4532","LU1674673428.USD","LU0882574055.USD","IBBQ","LU1061106388.HKD","LU1430594728.SGD","BMED","LU0823416689.USD","IE00BKVL7J92.USD","TBXU","GILD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232279","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232279","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232279?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 2.82% to $143.44 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.87% to 7,641.16 and Dow Jones Industrial Average  falling 1.32% to 52,759.21.The stock's fall snapped a seven-day winning streak.Gilead Sciences Inc. closed 8.81% below its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.21% to $267.37, Pfizer Inc.  fell 1.59% to $27.79, and Abbott Laboratories  fell 0.25% to $114.14.Trading volume  remained 286,153 below its 50-day average volume of 7.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU1066051498.USD","LU1571399168.USD","TMED","IBB","LU0965509010.AUD","LU1839511570.USD","LU2087621335.USD","LU1430594728.SGD","BK4583","BK4566","IE00B7SZLL34.SGD","BK4588","BK4568","LU0320765992.SGD","LU0114720955.EUR","LU1023059063.AUD","LU0861579265.USD","LU1061106388.HKD","LU1934455863.HKD","BK4139","LU0965509283.SGD","BMED","LU0234570918.USD","LU0289739699.SGD","LU1585245621.USD","BK4578","LU0058720904.USD","LU2324357040.USD","SG9999015978.USD","BK4550","IBBQ","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU1057294990.SGD","BK4532","LU0965508806.USD","BK4585","LU2468319806.SGD","LU1934455277.USD","SG9999015945.SGD","IE00BKVL7J92.USD","GILD","MEDI","TBXU","LU0882574055.USD","LU1934455194.USD","LU0965509101.SGD","IE0002270589.USD","LU1778281490.HKD","SG9999015986.USD","LU0122379950.USD","LU2112291526.USD","LU0109394709.USD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU0823416689.USD","LU1037948897.HKD","LU1037948541.HKD","LU1674673691.USD","BBH","BIB","LU1674673428.USD","IE00B19Z3B42.SGD","LU2089984988.USD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660847530","title":"Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2660847530","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660847530?lang=en_us&edition=fundamental","pubTime":"2026-08-20 05:01","pubTimestamp":1787173260,"startTime":"0","endTime":"0","summary":"DJ Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Quest Diagnostics Inc.  advanced 2.33% to $241.76 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.21% to 7,707.98 and the Dow Jones Industrial Average  rising 0.22% to 53,463.05.This was the stock's third consecutive day of gains.Quest Diagnostics Inc. hit a new 52-week high, surpassing its previous peak of $240.13, which the company reached on July 28th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as UnitedHealth Group Inc.  fell 1.35% to $388.61, IQVIA Holdings Inc.  rose 3.85% to $249.28, and Centene Corp.  fell 0.80% to $64.70.Trading volume  remained 33,338 below its 50-day average volume of 957,070.Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","DGX","LU1854103824.USD","BK4583","LU2506951958.HKD","LU2506952170.USD","BK4588","BK4567","LU0823417737.USD","LU0950375773.USD","BK4585","LU2506951875.HKD","LU1854104046.USD","LU2506952097.USD","LU0823417653.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473115","title":"Moderna Inc. Stock Rallies 177.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473115?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. sailed 177.0% to $174.38 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,331.09 and the Dow Jones Industrial Average rising 0.2% to 53,463.05.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $85.60, which the company achieved on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $273.41, Pfizer Inc. rose 3.6% to $28.24, and Gilead Sciences Inc. rose 2.90% to $147.60.Trading volume totaled 187.3 million, compared to the 50-day average of 7.3 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","IE00BKVL7J92.USD","BK4548","LU0965509010.AUD","LU0965509101.SGD","IBBQ","LGHT","IE00B19Z3581.USD","BBH","LU1778281490.HKD","IE00BZ1G4Q59.USD","MRNA","IE00B19Z3B42.SGD","TBXU","LU1430594728.SGD","LU1934455194.USD","LU1585245621.USD","LU1571399168.USD","LU1934455277.USD","IDNA","LU0234570918.USD","BK4583","IE0002270589.USD","LU1934455863.HKD","TMED","BK4139","BK4533","BK4578","SG9999015952.SGD","LU0965508806.USD","LU2324357040.USD","LU0320765992.SGD","MRNX","GNOM","BMED","WDNA","IBB","LU0861579265.USD","LU0889565916.HKD","BK4588","IE00B7SZLL34.SGD","GILD","LU0122379950.USD","LU0965509283.SGD","SG9999015978.USD","MRNY","LU0289739699.SGD","BIB","IE00BSNM7G36.USD","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660027424","title":"Viatris' China Policy Concerns Overstated, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660027424","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660027424?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:16","pubTimestamp":1787156202,"startTime":"0","endTime":"0","summary":"Viatris'  China business remains resilient despite concerns over the country's new volume-control policy, UBS Securities said in a Wednesday note.Concerns seem \"overstated\" given the China business' increasing profit contribution, above-average margins and shift toward retail and e-commerce channels. Viatris has also raised its outlook for its China business twice this year, the investment firm said.The volume-control policy could impact Viatris' public hospital volumes, but only to a limited extent that should still be offset by retail and self-pay segments. The new policy is also expected to have limited impact on Viatris' larger peers, based on commentary from those companies with significant operations in China, according to the note.About 25% of Viatris' China business comes from public hospitals, while retail and e-commerce channels now account for about 50%, up from roughly 40% in 2021, UBS said. The analysts also noted that key products including Lipitor, Norvasc and Viagra hav","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4583","BK4007","BK4588","VTRS","LU2087621335.USD","BK4585","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":50,"code":"91000000","status":"200"}]}}